• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

260.79 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 320
Open 260.79
Bid (Size) 255.84 (80)
Ask (Size) 272.07 (40)
Prev. Close 260.79
Today's Range 260.79 - 260.79
52wk Range 199.92 - 293.81
Shares Outstanding 146,234,244
Dividend Yield 0.92%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ResMed Inc. (NYSE:RMD) Emerges as a Prime Quality Investing Candidate ↗
February 23, 2026
Via Chartmill
News headline image
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?
February 15, 2026
Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks

Performance

YTD
+6.5%
+6.5%
1 Month
+2.1%
+2.1%
3 Month
+4.1%
+4.1%
6 Month
-8.8%
-8.8%
1 Year
+13.6%
+13.6%

More News

Read More
News headline image
3 Quality Compounders to Consider Right Now
February 11, 2026
Via StockStory
News headline image
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
February 05, 2026
Via StockStory
Topics Earnings Economy
ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion ↗
January 29, 2026
Via Chartmill
ResMed Inc (NYSE:RMD) Stands Out as a High-Quality Dividend Stock ↗
January 29, 2026
Via Chartmill
ResMed Inc. (NYSE:RMD) Embodies Quality Investing Principles ↗
January 16, 2026
Via Chartmill
News headline image
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth
January 30, 2026
Via StockStory
Topics Economy
News headline image
ResMed (RMD) Q2 2026 Earnings Call Transcript ↗
January 29, 2026
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations
January 29, 2026
Via StockStory
News headline image
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
January 29, 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect
January 27, 2026
Via StockStory
News headline image
1 Safe-and-Steady Stock Worth Investigating and 2 We Find Risky
January 25, 2026
Via StockStory
News headline image
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
January 14, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Beyond the ZZZs: Stanford’s SleepFM Turns a Single Night’s Rest into a Diagnostic Powerhouse
January 14, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?
January 13, 2026
Via StockStory
Topics Stocks
News headline image
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
January 08, 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid
December 28, 2025
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
December 21, 2025
Via StockStory
News headline image
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off
December 16, 2025
Via StockStory
Topics Stocks
News headline image
Which S&P500 stocks are moving before the opening bell on Wednesday? ↗
December 10, 2025
Via Chartmill
News headline image
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
December 08, 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
US Stock Market Rides High: Fed Rate Cut Fuels Optimism as Indices Eye Record Peaks
December 10, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Q3 2025 Earnings Showcase Corporate Resilience Amidst AI Boom, But Future Growth Faces Scrutiny
December 09, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Government

Frequently Asked Questions

Is ResMed Inc. Common Stock publicly traded?
Yes, ResMed Inc. Common Stock is publicly traded.
What exchange does ResMed Inc. Common Stock trade on?
ResMed Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for ResMed Inc. Common Stock?
The ticker symbol for ResMed Inc. Common Stock is RMD on the New York Stock Exchange
What is the current price of ResMed Inc. Common Stock?
The current price of ResMed Inc. Common Stock is 260.79
When was ResMed Inc. Common Stock last traded?
The last trade of ResMed Inc. Common Stock was at 02/23/26 07:00 PM ET
What is the market capitalization of ResMed Inc. Common Stock?
The market capitalization of ResMed Inc. Common Stock is 38.14B
How many shares of ResMed Inc. Common Stock are outstanding?
ResMed Inc. Common Stock has 38B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap